• Info
  • Insider Ownership

Insider Trading & Ownership of Anthony J. Polverino

Location
Hackensack, NJ
Summary
The estimated net worth of Anthony J. Polverino is at least $170,062 dollars as of 03 Jan 2025. Anthony J. Polverino is the Chief Scientific Officer of Zymeworks Inc. and owns shares of Zymeworks BC Inc. stock worth about $164.2K. Anthony J. Polverino is the Director of BRAINSTORM CELL THERAPEUTICS INC. and owns shares of BRAINSTORM CELL THERAPEUTICS INC. (BCLI) stock worth about $5.9K.
Signature
/s/ Anthony J. Polverino
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Anthony J. Polverino and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Sign up to save research and follow filings

Quick Takeaways

  • Anthony J. Polverino has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $170,062.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Zymeworks Inc. ($164,196).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Anthony J. Polverino

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ZYME Zymeworks Inc. Chief Scientific Officer $164,196 07 Jan 2022
BCLI BRAINSTORM CELL THERAPEUTICS INC. Director $5,866 01 Jan 2025

Insider Transactions Reported by Anthony J. Polverino:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.